Last reviewed · How we verify
Dengvaxia US Pregnancy Registry (DNG00044)
The primary objective of this study is to assess maternal, obstetrical, pregnancy, and neonatal and infant outcomes among women and their offspring(s) vaccinated with Dengvaxia during their pregnancy
Details
| Lead sponsor | Sanofi Pasteur, a Sanofi Company |
|---|---|
| Status | RECRUITING |
| Enrolment | 500 |
| Start date | Sun Jan 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Jun 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Dengue Virus Infection
Interventions
- Dengue Tetravalent Vaccine, Live
Countries
Puerto Rico